Loading company details...
Latest Form 4 (Nov 3, 2026): Paul J. Diaz (Director): Grant/Award of 613 shares, $91.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Paul J. Diaz | Grant/Award | 613 | $91.7K |
| Oct 1, 2026 | Christine E. Seidman | Grant/Award | 56 | $8.1K |
| Oct 1, 2026 | Surendralal Lanca Karsanbhai | Grant/Award | 112 | $16.3K |
| Oct 1, 2026 | Mary Ellen Coe | Grant/Award | 206 | $30.0K |
| Aug 13, 2026 | Chirfi Guindo, EVP, Access, Policy & Comms | Sale | 10,000 | $1.35M |
| Aug 13, 2026 | Jennifer Zachary, EVP, General Counsel | Exercise/Conversion | 41,494 | $4.89M |
| Aug 12, 2026 | Richard R. DeLuca, EVP&Pres, Merck Animal Heallth | Sale | 20,784 | $2.71M |
| Aug 10, 2026 | Richard R. DeLuca, EVP&Pres, Merck Animal Heallth | Sale | 805 | $105.5K |
| Aug 7, 2026 | David R. Maraldo, EVP & Pres. MMD | Exercise/Conversion | 6,311 | $465.3K |
| Aug 7, 2026 | David Michael Williams, EVP,Chief Info&Digital Officer | Exercise/Conversion | 4,600 | $357.1K |